ISSN 1526-5161, 1536-0075
35 papers in the library · 180 citations · publishing 2007-2026
The American Journal of Bioethics 2025 Shen Pan, David Wendler 1 citation
Increased interest in psychedelic treatments has raised concern regarding consent and whether it can be sufficiently informed. One source of concern is that psychedelic substances are prone to elic...
The American Journal of Bioethics 2025 Juuso Kähönen, Joel Janhonen, Joona Räsänen 1 citation
The use of psychedelics has recently gained increased interest among bioethicists, as the articles published in this journal attest. Some of the recent scholarship suggests that psychedelic experie...
The American Journal of Bioethics 2025 Susan Lee, Mikaela Kim, Grayson R Jackson et al. 1 citation
Drawing on comparisons to genetic exceptionalism, Cheung et al. (2025) reject psychedelic exceptionalism—that psychedelics raise unique concerns regarding increased vulnerability and diminished aut...
The American Journal of Bioethics 2025 K. Blevins 1 citation
Psychedelic ethics is at a crossroads. Confronted with the undeniable harm wrought by a widespread embrace of exceptionalism, many are approaching psychedelics not only in the context of urgent men...
The American Journal of Bioethics 2025 Naomi Scheinerman, Claire Erickson 1 citation
Exceptionalism in bioethics generally refers to the idea that a particular medical development or intervention warrants special consideration, either ethically or legally, given its unique features...
The American Journal of Bioethics 2025 Katrina Debonis, Walter Dunn, Thomas B. Strouse
The resurgence of psychedelic research has brought with it unique ethical considerations, including the role of personal psychedelic experience among facilitators. Some have argued that personal ps...
The American Journal of Bioethics May 2, 2024 Edward Jacobs, Brian D. Earp, Paul S. Appelbaum et al. 29 citations
The first Hopkins-Oxford Psychedelic Ethics (HOPE) workshop convened to discuss ethical matters relating to psychedelics in August 2023 at the University of Oxford.The organizers (BDE, DBY, EJ) aim...
The American Journal of Bioethics 2016 Michael H Andreae, Evelyn Rhodes, Tyler Bourgoise et al.
We examine the ethical, social, and regulatory barriers that may hinder research on therapeutic potential of certain controversial controlled substances like marijuana, heroin, or ketamine. Hazards for individuals and society and potential adverse effects on communities may be good reasons for limiting access and justify careful monitoring of these substances. Overly strict regulations, fear of...
The American Journal of Bioethics October 13, 2008 Albert R. Jonsen 4 citations
If I were the organizer of a conference on brain imaging, consciousness, and ethics, I would give it the name encephaloethics, the ethics of the brain. I know well that many commentators disdain th...
The American Journal of Bioethics September 1, 2007 Neil Levy
The extended mind thesis is the claim that mental states extend beyond the skulls of the agents whose states they are. This seemingly obscure and bizarre claim has far-reaching implications for neuroethics, I argue. In the first half of this article, I sketch the extended mind thesis and defend it against criticisms. In the second half, I turn to its neuroethical implications. I argue that the...